In a recent legal proceeding at Joint Base Lewis-McChord in Washington state, Army Captain Brandon Jones-Adams, 34, was sentenced to 12 years in prison following his guilty plea to charges including domestic violence, fraternization, and conduct unbecoming of an officer. The sentencing came after he admitted to intentionally administering the abortion drug mifepristone to his pregnant girlfriend, resulting in her miscarriage during the early stages of her second trimester. As part of the judgment, Jones-Adams was also dismissed from the military and lost all entitlements to pay and allowances.
According to official reports, Jones-Adams obtained mifepristone through an online provider using a false identity. He had begun a relationship with the junior enlisted soldier in November 2024, and she became pregnant in May 2025 while both were stationed in South Korea. They were subsequently reassigned to a base in Washington state. On August 21, 2025, the victim was at Jones-Adams' residence in Puyallup, Washington, when he prepared a drink for her. After consuming it, she noticed residue in the cup and suspected that a substance had been added. This suspicion was confirmed when she experienced severe cramping and sought medical attention at the base hospital, where she miscarried in her 13th week of pregnancy.
Mifepristone is currently approved by the FDA for use up to 10 weeks of gestation under the Risk Evaluation and Management Strategy. However, the drug can now be prescribed online and delivered by mail due to changes implemented in 2023. Investigators examining Jones-Adams' digital records discovered that he had made multiple attempts to obtain mifepristone from alternative sources, indicating a pattern of behavior aimed at acquiring the medication.
This case highlights ongoing concerns regarding the accessibility of mifepristone, especially in light of the Supreme Court’s 2022 ruling that overturned Roe v. Wade. Pro-life organizations argue that the ease of obtaining the drug online poses significant risks, particularly in cases of abuse. These groups have documented instances where individuals have been harmed or forced to terminate pregnancies against their will through the use of mifepristone acquired via mail order.
One such example involves Rosalie Markezich, a Louisiana resident who claims her partner ordered mifepristone online and pressured her to take it, leading to the loss of her pregnancy. Markezich is one of the plaintiffs in the lawsuit Louisiana v. FDA, which challenges the current regulations surrounding the distribution of mifepristone. She expressed strong belief that if mail-order abortions were not available, she would still have her child.
In response to these concerns, a coalition of 83 pro-life organizations has called upon Assistant Attorney General Todd Blanche to initiate a consent decree that would reinstate the in-person dispensing requirement for mifepristone while the FDA evaluates the drug’s safety profile. The Justice Department, however, maintains that the FDA should be permitted to complete its assessment without interference, arguing that premature intervention could disrupt the regulatory process and hinder thorough research into potential safety issues associated with mifepristone.
3 reports
The Washington TimesParty-alignedRightFactual 95Objective 654 days agoAn Army captain, Capt. Brandon Jones-Adams, was sentenced to 12 years in prison for poisoning his pregnant girlfriend's drink with the abortion drug mifepristone, resulting in her miscarriage. The incident occurred while both were stationed at Joint Base Lewis-McChord in Washington state. Jones-Adams used a fake name to obtain the drug online, which had become more accessible after the FDA removed in-person dispensing requirements in 2023. His actions led to the loss of the unborn child, and he was also dismissed from the military and stripped of benefits. Pro-life groups have highlighted similar cases, criticizing the current regulations that allow mail-order abortions, which they argue pose risks to pregnant individuals.
Bias read (Right): The article frames the case as a violation of personal autonomy and highlights concerns over the accessibility of mifepristone, particularly under the Biden administration's policies. It emphasizes the risks associated with mail-order abortions and criticizes the lack of safeguards, aligning with a右
Why these scores (Factual 95 · Objective 65): Factual accuracy is high, aligning closely with the primary source document regarding the guilty plea, sentencing, and details of the incident. However, the article uses emotionally charged language such as 'disgusting act' and frames the case in a moralistic tone, reducing objectivity.
The NationIndependentLeftFactual 50Objective 804 days agoThe article discusses the ongoing political and legal battles over abortion rights in the United States, focusing on efforts to restrict access to telemedicine abortions. It notes that while President Donald Trump has remained relatively silent on abortion issues before the midterms, his administration has taken steps to challenge the availability of mifepristone, a medication used for early-term abortions. A recent Supreme Court ruling temporarily blocked Louisiana's attempt to require in-person visits for mifepristone, but the decision deferred the safety evaluation to the FDA. Despite calls to delay the review until after the midterms, the FDA has proceeded with its investigation. The article highlights the decline in physical abortion clinics and the increasing reliance on telemedicine, which is now responsible for over 30% of safe abortions. It suggests that these attacks on abortion access are part of a broader strategy to align with conservative policies.
Bias read (Left): The article frames the restrictions on abortion access as politically motivated, emphasizing the role of the Trump administration and its alignment with anti-abortion groups. It portrays the FDA's actions as influenced by political incentives rather than purely scientific considerations. The tone is
Why these scores (Factual 50 · Objective 80): The article mentions mifepristone and abortion rights but does not reference the specific case or the primary source document. It presents a political perspective on abortion issues without discussing the actual event. Factuality is low due to lack of direct connection to the primary source.
STAT NewsIndependentCenterFactual 0Objective 03 days agoThe article discusses several key developments in U.S. health and legal policies. First, it highlights concerns about potential conflicts of interest among new FDA panelists overseeing peptide manufacturing, noting that many are affiliated with companies promoting peptides. Second, it reports that 26 states have sued the federal government to block new Medicaid work requirements, which would mandate 80 hours of monthly work, school, or volunteering for most recipients, with exceptions for those deemed 'medically frail.' Third, it mentions the Supreme Court agreeing to consider a case involving parental rights in transgender care, specifically regarding adolescents seeking gender-affirming treatment after running away from home.
Bias read (Center): The article presents multiple issues without overtly favoring any political side. While it covers politically sensitive topics like Medicaid work requirements and parental rights in healthcare decisions, the framing remains balanced, presenting facts and expert opinions without clear ideological sl抗
Why these scores (Factual 0 · Objective 0): This article is completely unrelated to the primary source document and discusses entirely different topics such as Medicaid work requirements and FDA panelists. It does not address the event covered in the primary source.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.
Become a Supporter
United States
